Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Sep 7, 2025, 8:00 PM EDT
Abattis Bioceuticals Market Cap
Abattis Bioceuticals has a market cap or net worth of $476.00 as of September 9, 2025.
Market Cap
476.00
Enterprise Value
n/a
Revenue
269.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 476.00, a decrease of -99.97%. That is a compound annual growth rate of -46.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 476.00 | - |
| Dec 30, 2024 | 476.00 | - |
| Dec 29, 2023 | 476.00 | - |
| Dec 30, 2022 | 476.00 | - |
| Dec 31, 2021 | 476.00 | -99.99% |
| Dec 31, 2020 | 5.95M | 177.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |